New hope for bladder cancer patients who failed standard therapy
Disease control
Recruiting now
This early-stage study tests a new drug called RAG-01 in about 72 adults with a type of bladder cancer (non-muscle-invasive) that did not get better with standard BCG therapy. The main goals are to check the drug's safety, find the best dose, and see if it helps control the cance…
Phase: PHASE1 • Sponsor: Ractigen Therapeutics. • Aim: Disease control
Last updated May 14, 2026 12:03 UTC